How to transition existing trials under EU-CTR

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Article

How a joined-up development strategy pays off for early-stage biotechs

May 19, 2021

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Article

Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct

Sep 14, 2021

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Article

Decentralized trial tools and technologies are here to stay: A regulatory perspective

Jul 23, 2021

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Article

EU Orphan Drug Designation – overcoming regulatory challenges

Jul 20, 2022

Blog

End-to-end risk management: Getting the most from your program

Apr 4, 2022

Podcast

Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment

May 9, 2022